Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10014326HBVENSG00000082175.16protein_codingPGRYesNo5241P06401
TVIS30086512HIVENSG00000082175.16protein_codingPGRYesNo5241P06401
TVIS20022380HPVENSG00000082175.16protein_codingPGRYesNo5241P06401
TVIS20049966HPVENSG00000082175.16protein_codingPGRYesNo5241P06401
TVIS20049934HPVENSG00000082175.16protein_codingPGRYesNo5241P06401
TVIS44013458HTLV-1ENSG00000082175.16protein_codingPGRYesNo5241P06401
TVIS44020347HTLV-1ENSG00000082175.16protein_codingPGRYesNo5241P06401
TCGA Plot Options
Drug Information
GenePGR
DrugBank IDDB06713
Drug NameNorelgestromin
Target IDBE0000557
UniProt IDP06401
Regulation Typeagonist
PubMed IDs19962254; 1324557; 17107221; 7750291; 8384965
CitationsPasqualini JR: Breast cancer and steroid metabolizing enzymes: the role of progestogens. Maturitas. 2009 Dec;65 Suppl 1:S17-21. doi: 10.1016/j.maturitas.2009.11.006. Epub 2009 Dec 3.@@London RS, Chapdelaine A, Upmalis D, Olson W, Smith J: Comparative contraceptive efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive. Acta Obstet Gynecol Scand Suppl. 1992;156:9-14.@@Graziottin A: A review of transdermal hormonal contraception : focus on the ethinylestradiol/norelgestromin contraceptive patch. Treat Endocrinol. 2006;5(6):359-65.@@Kuhnz W, Fritzemeier KH, Hegele-Hartung C, Krattenmacher R: Comparative progestational activity of norgestimate, levonorgestrel-oxime and levonorgestrel in the rat and binding of these compounds to the progesterone receptor. Contraception. 1995 Feb;51(2):131-9.@@Juchem M, Pollow K, Elger W, Hoffmann G, Mobus V: Receptor binding of norgestimate--a new orally active synthetic progestational compound. Contraception. 1993 Mar;47(3):283-94.
GroupsApproved; Investigational
Direct ClassificationEstrane steroids
SMILES[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(C=C3CC[C@@]21[H])=NO
Pathways
PharmGKB
ChEMBLCHEMBL1200807